PURPOSE: This study examined whether race/ethnicity had differential effects on breast cancer care and survival across age strata and cohorts within stages of disease. METHODS: The Detroit Cancer Registry provided 25,997 breast cancer cases. African American and non-Hispanic white, older Medicare-eligible and younger non-eligible women were compared. Successive historical cohorts (1975-1980 and 1990-1995) were, respectively, followed until 1986 and 2001. RESULTS: African American disadvantages on survival and treatments increased significantly, particularly among younger women who were much more likely to be uninsured. Within node positive disease all treatment disadvantages among younger African American women disappeared with socioeconomic adjustment. CONCLUSIONS: Growth of this racial divide implicates social, rather than biological, forces. Its elimination will require high quality health care for all.
PURPOSE: This study examined whether race/ethnicity had differential effects on breast cancer care and survival across age strata and cohorts within stages of disease. METHODS: The Detroit Cancer Registry provided 25,997 breast cancer cases. African American and non-Hispanic white, older Medicare-eligible and younger non-eligible women were compared. Successive historical cohorts (1975-1980 and 1990-1995) were, respectively, followed until 1986 and 2001. RESULTS: African American disadvantages on survival and treatments increased significantly, particularly among younger women who were much more likely to be uninsured. Within node positive disease all treatment disadvantages among younger African American women disappeared with socioeconomic adjustment. CONCLUSIONS: Growth of this racial divide implicates social, rather than biological, forces. Its elimination will require high quality health care for all.
Authors: Kristie Long Foley; Gretchen Kimmick; Fabian Camacho; Edward A Levine; Rajesh Balkrishnan; Roger Anderson Journal: Breast Cancer Res Treat Date: 2006-07-13 Impact factor: 4.872
Authors: Lydia Voti; Lisa C Richardson; Isildinha Reis; Lora E Fleming; Jill Mackinnon; Jan Willem W Coebergh Journal: Breast Cancer Res Treat Date: 2005-10-22 Impact factor: 4.872
Authors: Jennifer J Griggs; Eva Culakova; Melony E S Sorbero; Marek S Poniewierski; Debra A Wolff; Jeffrey Crawford; David C Dale; Gary H Lyman Journal: J Clin Oncol Date: 2007-06-20 Impact factor: 44.544
Authors: Nancy Krieger; Jarvis T Chen; Pamela D Waterman; David H Rehkopf; S V Subramanian Journal: Am J Public Health Date: 2003-10 Impact factor: 9.308
Authors: Shoshana Adler Jaffe; Orrin Myers; Angela L W Meisner; Charles L Wiggins; Deirdre A Hill; Jean A McDougall Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-12-03 Impact factor: 4.254
Authors: Lawrence B Marks; Constance Cirrincione; Thomas J Fitzgerald; Frances Laurie; Arvin S Glicksman; James Vredenburgh; Leonard R Prosnitz; Elizabeth J Shpall; Michael Crump; Paul G Richardson; Michael W Schuster; Jinli Ma; Bercedis L Peterson; Larry Norton; Steven Seagren; I Craig Henderson; David D Hurd; William P Peters Journal: Int J Radiat Oncol Biol Phys Date: 2009-09-09 Impact factor: 7.038
Authors: Kevin M Gorey; Isaac N Luginaah; Eric J Holowaty; Guangyong Zou; Caroline Hamm; Emma Bartfay; Sindu M Kanjeekal; Madhan K Balagurusamy; Sundus Haji-Jama; Frances C Wright Journal: BMC Public Health Date: 2012-10-24 Impact factor: 3.295
Authors: Kevin M Gorey; Isaac N Luginaah; Eric J Holowaty; Guangyong Zou; Caroline Hamm; Madhan K Balagurusamy Journal: Int J Equity Health Date: 2013-01-14
Authors: Michael S Simon; Sreejata Raychaudhuri; Lauren M Hamel; Louis A Penner; Kendra L Schwartz; Felicity W K Harper; Hayley S Thompson; Jason C Booza; Michele Cote; Ann G Schwartz; Susan Eggly Journal: Front Oncol Date: 2021-07-07 Impact factor: 6.244